Literature DB >> 15037073

A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.

Ayelet Armon-Omer1, Adolf Graessmann, Abraham Loyter.   

Abstract

In spite of recent efforts to elucidate the nuclear import pathway of the human immunodeficiency virus type 1 (HIV-1) integrase protein (IN), its exact route as well as the domains that mediate its import are still unknown. Here, we show that a synthetic peptide bearing the amino acid residues 161-173 of the HIV-1 IN is able to mediate active import of covalently attached bovine serum albumin molecules into nuclei of permeabilized cells and therefore was designated as nuclear localization signal-IN (NLS(IN)). A peptide bearing residues 161-173 in the reversed order showed low karyophilic properties. Active nuclear import was demonstrated by using fluorescence microscopy and a quantitative ELISA-based assay system. Nuclear import was blocked by addition of the NLS(IN) peptide, as well as by a peptide bearing the NLS of the simian virus 40 T-antigen (NLS-SV40). The NLS(IN) peptide partially inhibited nuclear import mediated by the full-length recombinant HIV-1 IN protein, indicating that the sequence of the NLS(IN) is involved in mediating nuclear import of the IN protein. The NLS(IN) as well as the full-length IN protein interacted specifically with importin alpha, binding of which was blocked by the NLS(IN) peptide itself as well as by the NLS-SV40.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037073     DOI: 10.1016/j.jmb.2003.11.057

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism.

Authors:  Anna C Hearps; David A Jans
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

2.  Analysis of the viral elements required in the nuclear import of HIV-1 DNA.

Authors:  Lise Rivière; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Nucleus       Date:  2010-01-14       Impact factor: 4.197

Review 4.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

5.  Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 protein.

Authors:  Stephanie De Houwer; Jonas Demeulemeester; Wannes Thys; Oliver Taltynov; Katarina Zmajkovicova; Frauke Christ; Zeger Debyser
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

6.  Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.

Authors:  Sergey Iordanskiy; Mackenzie Waltke; Yanjun Feng; Charles Wood
Journal:  Retrovirology       Date:  2010-10-12       Impact factor: 4.602

8.  Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA).

Authors:  Ruonan Zhang; Rajeev Mehla; Ashok Chauhan
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

Review 9.  Nuclear import by karyopherin-βs: recognition and inhibition.

Authors:  Yuh Min Chook; Katherine E Süel
Journal:  Biochim Biophys Acta       Date:  2010-10-26

10.  An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.

Authors:  Hayate Merad; Horea Porumb; Loussiné Zargarian; Brigitte René; Zeina Hobaika; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.